Month: April 2020

Indian Authority Remains Silent About FDA’s Warnings Against Widespread Use of Hydroxychloroquine (HCQ) In COVID-19 Patients: British Medical Journal (BMJ) Publishes Urgent Plea From PBT President As a “Rapid Response”

The British Medical Journal (BMJ) today published online a “Rapid Response” written by PBT president and USA-based HIV/AIDS scientist, Dr. Kunal Saha, in regard to the rampant use of anti-malarial drug, Hydroxychloroquine (HCQ), in treatment of COVID-19 patients in India (see below, also available at the link: https://www.bmj.com/content/369/bmj.m1432/rapid-responses). The US Food and Drug Administration (FDA) …

FDA Issues Warnings For Serious Side-effects and Death in COVID-19 Patients Treated With Hydroxychloroquine: PBT Writes To ICMR and Health Ministry For Immediate Action

Food & Drug Administration (FDA) in USA issued a stark warning today on the use of anti-malarial drug, Hydroxychloroquine (HCQ), either alone or in combination with Azithromycin (AZM), in the treatment of COVID-19 patients despite president Trump’s vociferous promotion of HCQ (see FDA release below). PBT already lodged a writ petition (PIL) in the Supreme …

New Study Finds “Increased Overall Mortality” Associated With COVID-19 Patients Treated With Hydroxychloroquine (HCQ) and No Benefit In Patients Treated With HCQ and Azithromycin (AZM): PBT Submits Urgent Appeal to Stop Widespread Use of HCQ and AZM In COVID-19

A multi-center study with 368 hospitalized COVID-19 patients in VA hospitals across US was released today underscoring the serious risks involved for “off-label” use of anti-malarial, Hydroxychloroquine (HCQ) and/or broad-spectrum antibiotic, Azithromycin (AZM) in the treatment for COVID-19 patients. The online release of this study found no evidence of any benefit for using HCQ and …

Treatment of COVID-19 Patients by “Off-label” Hydroxychloroquine and Azithromycin Raises Serious Concerns for Cardiovascular Side-effects: PBT Files Urgent PIL in SC Seeking Safety Changes and “Informed Consent”

Treatment guidelines issued by Ministry of Health and Family Welfare (MOHFQW) have recommended “off-label” use of highly controversial and unproven combination therapy with an anti-malarial drug, Hydroxychloroquine (HCQ) and broad-spectrum antibiotic, Azithromycin (AZM) for seriously ill ICU-bound COVID-19 patients. Serious warnings were issued last week through an urgent joint bulletin by American Heart Association (AHA), …

Supreme Court Held a Doctor as “Reckless” and “Unbecoming As a Doctor”, Mamata Banerjee Calls the Same Doctor as “Global Best” and Selects Him To Combat COVID-19 Pandemic In West Bengal

Dr. Sukumar Mukherjee is known all over India as the worst negligent physician against whom highest ever compensation (Rs. 11.5 crore) in Indian medical history was awarded by Supreme Court of India for causing death of Anuradha Saha, wife of PBT president Dr. Kunal Saha. While awarding the highest compensation in 2013, Apex Court also …

American Medical Association (AMA) Warns Against Chloroquine In COVID-19 as It Can Cause Serious Side-effects Including Death As Trump and Indian Government Promote These Drugs: PBT Writes To ICMR Against Prophylactice Use of Chloroquine and Hydroxychloroquine

As US president Donald Trump on a wild run openly promoting widespread use of anti-malarial drugs, Chloroquine and Hydroxychloroquine, to combat COVID-19 without any scientific evidence and against the advice of top researchers at Center for Disease Control (CDC) and National Institute of Health (NIH), Indian government has gone a step further as Indian Council …